Keros Therapeutics' Licensing Deal With Takeda Aligns With Broader Opportunity...

Published on 4 Dec 2024 on Benzinga · via Yahoo Finance

On Tuesday, Takeda Pharmaceutical Company Limited (NYSE:TAK) entered into an exclusive licensing...

Read the rest of the article

Start tracking your investments with Statfolio

Takeda Pharmaceutical Company Limited (NYSE:TAK) announced on Friday that the Japanese Ministry o...

Benzinga · via Yahoo Finance 28 Dec 2024

Low-cost index funds make it easy to achieve average market returns. But if you invest in individ...

Simply Wall St. · via Yahoo Finance 10 Dec 2024

On Tuesday, Takeda Pharmaceutical Company Limited (NYSE:TAK) entered into an exclusive licensing...

Benzinga · via Yahoo Finance 4 Dec 2024

We recently published a list of 12 Most Profitable Pharmaceutical Stocks Right Now. In this artic...

Insider Monkey · via Yahoo Finance 1 Dec 2024

BOSTON (WWLP) – A former employee at a Massachusetts pharmaceutical company was sentenced to pris...

WWLP Springfield · via Yahoo News 2 Nov 2024

We recently compiled a list of the 10 Best Japanese Stocks To Buy Now. In this article, we are go...

Insider Monkey · via Yahoo Finance 24 Sep 2024

We recently compiled a list of the 10 Cheap Pharmaceutical Stocks to Buy According to Short Selle...

Insider Monkey · via Yahoo Finance 24 Aug 2024

Japan's Takeda Pharma Outlines $900M Overhaul To Boost Growth, As 2023 Profit Fall Over 50% On Th...

Benzinga via Yahoo Finance 9 May 2024

In this article, we will be taking a look at the 20 fastest growing health tech companies in the ...

Insider Monkey via Yahoo Finance 25 Apr 2024

Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today: Takeda Pharmaceutical Co...

Zacks via Yahoo Finance 25 Apr 2024